X4 Pharmaceuticals, Inc. announced the appointment of Françoise de Craecker to the company’s Board of Directors. Ms. de Craecker’s appointment expands the X4 Board of Directors to nine members. Ms. de Craecker joins the X4 Board of Directors following a distinguished career building multi-functional teams, formulating global commercial strategies for orphan drug and gene therapy products, and successfully launching multiple products across the globe. She also currently serves as an Independent Director of the French biopharmaceutical company GenSight. .